73
Participants
Start Date
November 29, 2010
Primary Completion Date
September 15, 2014
Study Completion Date
September 15, 2014
adult human mesenchymal stem cells
PROCHYMAL will be administered IV in a total volume of 300 ml (200 million cells) at a rate of 4-6 ml/minute. Treatments will be administered on Days 42-45, Days 84-87, and Days 126-129 following first infusion in Protocol 603.
Weill Cornell Medical College, New York
Mount Sinai School of Medicine, New York
Chevy Chase Clinical Research, Chevy Chase
University of Maryland, Baltimore, Baltimore
McGuire Research Institute, Richmond
Shafran Gastroenterology Center, Winter Park
Clinical Research of West Florida, Clearwater
Vanderbilt University Medical Center, Nashville
Gastroenterology Center of the Midsouth, PC, Germantown
University of Chicago, Chicago
Saint Louis Center for Clinical Research, St Louis
St. Louis Center for Clinical Studies, St Louis
Cotton-O'Neil Clinical Research Center, Topeka
Baylor University Medical Center, Dallas
University of California, San Francisco, San Francisco
Dartmouth HItchcock Medical Center, Lebanon
Royal Adelaide Hospital, Adelaide
Royal Melbourne Hospital, Melbourne
University of Otago, Christchurch
Waikato Hospital, Hamilton
Lead Sponsor
Mesoblast, Inc.
INDUSTRY